MDMA ("Ecstasy"), Post-Traumatic Stress Disorder (PTSD), Psychotherapy & MAPS | Berra Yazar-Klosinski | #26

Mind & Matter

English - June 11, 2021 04:00 - 1 hour - 75.2 MB - ★★★★★ - 15 ratings
Science Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Chris Timmermann: Dimethyltryptamine (DMT), Brain Waves & the Psychedelic Experience | #25

Next Episode: Genomics, CRISPR, Synthetic Biology, Biotechnology Startups, & Succeeding With Disabilities | George Church | #27

Send us a Text Message.

Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.

Support the Show.

All episodes (audio & video), show notes, transcripts, and more at the M&M Substack

Try Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase.

Try SiPhox Health—Affordable, at-home bloodwork w/ a comprehensive set of key health marker. Use code TRIKOMES for a 10% discount.

Try the Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off.

Learn all the ways you can support my efforts